Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced HES 130/0.42 for target-controlled fluid therapy in elective pancreatic surgery
2008-004175-22Phase 4Completed
- Sponsor
- B. Braun
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hetastarch (3 arms), sponsored by B. Braun. Primary endpoints: Intra-operative amount of colloidal volume replacement therapy and Days until fully on oral solid diet. Started Jan 2009; status: completed.
02
Drugs
hetastarch
Beyond the preview
Go deeper on 2008-004175-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004175-22.